The global safety syringe market was valued at US$ 7,416.3 million in 2023 and is expected to reach US$ 12,054.3 million in 2034. The market is expected to surge at a CAGR of 4.5% through 2034. It is anticipated to attain a value of around US$ 7,736.2 million in 2024.
| Attributes | Key Insights |
|---|---|
| Safety Syringe Market Size in 2023 | US$ 7,416.3 million |
| Estimated Safety Syringe Market Value (2024) | US$ 7,736.2 million |
| Forecast Safety Syringe Market Revenue (2034) | US$ 12,054.3 million |
| Value-based CAGR (2024 to 2034) | 4.5% |
Syringes are widely utilized in several medical settings, including hospitals and clinics, for vaccines, insulin administration, and other vital pharmacological therapies. Their uniform design allows healthcare service providers to offer consistent and controlled drug distribution, which improves patient safety and treatment efficacy.
Safety syringes are made with mechanisms that either retract, shield, or deactivate the needle after use to reduce the possibility of unintentional needlestick injuries. These syringes are frequently used in medical settings, such as blood collection, medication delivery, and immunizations.
The market for safety syringes is primarily driven by strict regulatory demands that encourage the use of safety devices, growing worries about the spread of blood-borne illnesses, and growing awareness of needlestick injuries. Continuous technological innovations and developments would aid in the creation of safer, more user-friendly syringes.
Global health initiatives such as immunization campaigns and efforts to combat infectious illnesses influence the need for safe syringes in the market. In the safety syringe industry, trends such as the growing use of self-administration tools, the demand for disposable syringes, and partnerships between significant competitors are driving growth.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global market for systematic syringes grew at a CAGR of 4.3% from 2019 to 2023. Several factors, including a greater understanding of the importance of needle stick injury prevention and healthcare worker safety, can be responsible for the rising sales of safety syringes. Healthcare workers who suffer needlestick injuries have a serious risk of contracting bloodborne infections like HIV, hepatitis B, and hepatitis C.
Safety syringes have become an essential device due to the healthcare industry's active search for ways to improve safety precautions. The healthcare industry's growing emphasis on safety at work standards and regulations is one of the key factors driving sales growth.
The usage of safety syringes has also increased due to rising awareness of infectious diseases, specifically in global health emergencies. Notably, the COVID-19 pandemic has highlighted the need for infection control procedures, compelling healthcare professionals to invest in safer medical equipment, such as syringes with enhanced security features.
Technological developments have also resulted in innovative syringe safety features, like automatic safety shields and retractable needles. These characteristics increase the general effectiveness and accessibility of healthcare environments while reducing the probability of needlestick injuries.
Considering the increasing demand for minimally invasive surgeries, technological advancements, and increased awareness of infectious diseases, the growth of safety syringes is anticipated. The global safety syringe market is expected to propel at a CAGR of 4.5% over the forecast period.
Increasing the number of internet users and raising awareness regarding e-commerce for healthcare products are changing the scenario of distribution channels. Several manufacturers are selling their products through e-commerce websites at the country level.
A handful of e-commerce websites strongly focus on disposable products only. Due to the growing usage of online sales, the growth through online sales is increasing and creating opportunities for the market.
Asia Pacific, Latin America, and the Middle East are the emerging markets in the world. Insulin syringes present a higher opportunity for safe syringes for regions with the leading population and diabetic rate in the world.
The healthcare infrastructure is developing with increasing funding and investment in research & development and technology. Hence, the demand for precise and standardized medical equipment is increasing.
Systematic syringes, with their precision in medicine administration, play an essential role in ensuring effective medication delivery. Rising healthcare investments make modern medical tools more affordable, ultimately creating a favorable environment for the market growth of safe syringes.
Principal Consultant
The unauthorized use of safety syringes for illegal purposes is a severe problem when such products are misused. Safety syringe sales for their intended medical uses can drop as a result of unethical users using this product for non-medical purposes, such as the injection of illegal narcotics.
The improper use of safety syringes contradicts the intended usage of these instruments and puts the general public's health at risk. The possibility of needle sharing among drug addicts increases the likelihood of spreading bloodborne pathogens like hepatitis and HIV.
They would add to a more significant public health emergency. Incorrect application of safety syringes has two problems: it reduces the market for appropriate medical usage and makes infectious disease transmission in communities harder. Factors such as the availability of safe syringes in the illegal marketplace and unethical usage of safe syringes could be barriers to the growth of the safe syringe market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The table below shows the estimated growth rates of the top five countries. India, China, and the United Kingdom are set to record higher CAGRs of 10.5%, 9.5%, and 2.2%, respectively, through 2034.
| Countries | Value CAGR |
|---|---|
| United States | 1.5% |
| China | 9.5% |
| Germany | 1.8% |
| United Kingdom | 2.2% |
| India | 10.5% |
The United States contributed as the profitable market, holding a global share of around 32.3% in 2023. The United States syringe market is expected to register a CAGR of 1.5% during the forecast period, owing to the rising number of minimally invasive procedures performed in the country.
There is an increasing need for precise and regulated drug administration as these procedures become increasingly common. Safety syringes are essential to the changing landscape of medical treatments in the United States because of the increased attention to patient safety and the efficacy of medication therapy.
China is projected to be the most attractive market globally in 2023, accounting for a market share of around 6.3%. Several factors, such as growing awareness of infectious disorders, a rise in healthcare spending, and the increasing prevalence of chronic disorders, are contributing to significant market growth. The need for safety syringes is further driven by the growing focus on preventative care and early intervention as China's healthcare system changes to meet the demands of an aging population.
Like several other nations, the United Kingdom has laws to encourage the use of safe syringes. Manufacturers and healthcare facilities must adhere to safety regulations and recommendations. There has probably been a rise in the use of safety syringes in the United Kingdom due to growing awareness of the dangers of needlestick injuries and the significance of safety for healthcare workers.
In the United Kingdom, healthcare practices are greatly influenced by the National Health Service (NHS). The NHS's deployment of safety syringes can significantly impact market dynamics. The nation's general attitude toward medical innovation is influencing the adoption of safe syringes with cutting-edge features and technologies.
The uptake of safety syringes is impacted by the condition of the healthcare system, including hospitals and clinics in India. Healthcare facilities with adequate equipment are more likely to incorporate safety syringes into their operations. Initiatives and public health campaigns geared toward lowering needlestick injuries and encouraging the use of safety syringes are fueling market expansion.
The COVID-19 pandemic has increased public knowledge of safe measures in healthcare. The pandemic's influence may have impacted the safety of syringe adoption on the order of importance for safety precautions. Government rules, including procurement procedures and reimbursement policies, are further influencing the safety syringe market in India.
Manufacturers of safe syringes and other medical devices must adhere to strict regulations in Japan. Adherence to safety standards and regulations is essential for market approval and entry. Safety syringe usage is rising in Japan due to increased knowledge about needlestick injury prevention, workplace safety, and healthcare safety.
Due to its aging population, Japan has a significant demand for healthcare services. Two primary drivers driving the market for safe syringes are the state of healthcare and the requirement for safe injection procedures.
The below section shows the retractable segment dominating by product type. It is expected to thrive at a 4.1% CAGR by 2034. Based on application, the subcutaneous segment is anticipated to hold a dominant share through 2034. It is set to exhibit a CAGR of 3.2% during the forecast period.
| Segment | Value CAGR (2024 to 2034) |
|---|---|
| Subcutaneous (Application) | 3.2% |
| Retractable (Product) | 4.1% |
| Hospitals (End-user) | 2.8% |
| Retail Sales (Distribution Channel) | 3.5% |
The retractable segment accounted for a dominant share of 68.2% in 2023. Due to more safety measures than non-retractable safety syringes, retractable syringes usually have more significant sales.
The design of retractable syringes mechanically pulls the needle back into the barrel after use, lowering the possibility of needlestick injuries and stopping the transmission of diseases. Retractable syringes have become more prevalent in healthcare settings due to their safety benefit, which has expanded their adoption.
The subcutaneous segment is leading the market with a share of 65.7% in 2023. In general, subcutaneous injections are less effective and painful than intramuscular injections, which go deeper into the muscle tissue.
Subcutaneous injections involve injecting medications into the fatty tissue just beneath the skin. Because of their smaller size, patients find subcutaneous injections utilizing systematic syringes more manageable.
Several drugs are designed to be administered subcutaneously, which makes it the preferred approach for a handful of therapeutic applications. Subcutaneous application with systematic syringes is more common due to a mix of patient comfort, convenience of administration, and pharmaceutical requirements.
The hospital segment is a leading end-user of the syringe market, with a 29.8% value share in 2023. The hospital segment leads the periodic syringe sales as the end-user due to the high volume of medical testing.
Safety syringes are necessary in hospitals to ensure proper medicine delivery, patient safety, and therapeutic effectiveness. Hospitals have higher revenues in this market than other end-users, including clinics or research institutions, because of the vital importance of healthcare interventions in these locations.
Leading companies are strategically making acquisitions and developing new products to strengthen their positions. Through acquisitions, businesses can expand their skills, penetrate new markets, and diversify their portfolios.
Ongoing product innovations ensure both innovation and competitiveness at the same time. The dynamic market for safety syringes is promoting growth and sustainability through the ability of key players to meet consumer expectations, adjust to evolving industry trends, and maintain a competitive edge through strategic actions.
For instance,
| Attribute | Details |
|---|---|
| Estimated Market Size (2024) | US$ 7,736.2 million |
| Forecast Market Size (2034) | US$ 12,054.3 million |
| Projected Growth Rate (2024 to 2034) | 4.5% |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | US$ million for Value |
| Key Regions Covered | North America; Latin America; South Asia and Pacific; East Asia; Western Europe; Eastern Europe; Middle East and Africa |
| Key Countries Covered | United States, Canada, Mexico, Brazil, Chile, the Rest of Latin America, China, Japan, South Korea, India, the Association of Southeast Asian Nations, Australia and New Zealand, the Rest of South Asia and Pacific, Germany, Italy, France, United Kingdom, Spain BENELUX, Nordic Countries, Rest of Western Europe, Russia, Hungary, Poland, Rest of Eastern Europe, Saudi Arabia, Türkiye, South Africa, Other African Union, Rest of Middle East and Africa |
| Key Segments Covered | Product, Application, Distribution Channel, End-user, and Region |
| Key Companies Profiled | Becton, Dickinson and Company; AdvaCare Pharma; Cardinal Health Inc.; DMC Medical Ltd.; Duopross Meditech Corp.; Haiou Medical; Kendall Healthcare; Lifelong Meditech (Group); Medicina (HMC Group); Medline Industries; Nipro Corporation; Numedico; Nemera; Retractable Technologies, Inc.; Revolutions Medical Corporation; Smith’s Medical, Inc. (ICU Medical, Inc.); Sol-Millennium Medical Group; Terumo Corporation; UltiMed, Inc. (Ulticare); Unilife Corporation; B. Braun Melsungen AG; Fresenius Kabi AG; West Pharmaceutical Services, Inc. |
| Report Coverage | Market Forecast, Competition Intelligence, Drivers, Restraints, Opportunities, Trends, Market Dynamics and Challenges, Strategic Growth Initiatives |
The market was worth US$ 7,416.3 million in 2023.
The market is expected to reach US$ 12,054.3 million in 2034.
The global market grew at a CAGR of 4.3% between 2019 and 2023.
The United States contributed US$ 2,393.3 million in 2022.
India is expected to surge at a CAGR of 10.5% by 2034.
The retractable segment held a prominent share of 68.2% in 2023.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Development/Innovation Trends
4. Value Added Insights
4.1. Product Adoption Analysis
4.2. Regulatory Scenario, By Country
4.3. Technology Evolution
4.4. Reimbursement Landscape
4.5. PESTEL Analysis by Region
4.6. PORTER Analysis
4.7. Value Chain Analysis
4.8. Unmet Needs and Opportunities
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global Healthcare Expenditure Outlook
5.1.2. Global Research and Development Funding Outlook
5.1.3. Global Life Expectancy Outlook
5.1.4. Parent Market Analysis
5.2. Forecast Factors - Relevance and Impact
5.2.1. GDP Growth
5.2.2. Healthcare Spending
5.2.3. Prevalence of Chronic Diseases
5.2.4. COVID-19 Pandemic
5.2.5. Product Adoption Rate
5.2.6. Regulatory Framework
5.2.7. Advancements in Technologies
5.2.8. Cost of Products
5.2.9. Global Vaccination Programs
5.2.10. Key Market Players Revenue Analysis
5.2.11. Recent Key Player Activities
5.2.12. Alternative Products
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Market Demand Volume (Units) Analysis 2019 to 2023 and Forecast, 2024 to 2034
6.1. Historical Market Volume (Units) Analysis, 2019 to 2023
6.2. Current and Future Market Volume (Units) Projections, 2024 to 2034
6.2.1. Y-o-Y Growth Trend Analysis
7. Global Market Demand Pricing Analysis 2019 to 2023 and Forecast, 2024 to 2034
7.1. Global Average Pricing Analysis Benchmark
7.2. Regional Pricing Analysis
7.3. Pricing Assumptions
8. Global Market Demand (in Value or Size in US$ million) Analysis 2019 to 2023 and Forecast, 2024 to 2034
8.1. Historical Market Value (US$ million) Analysis, 2019 to 2023
8.2. Current and Future Market Value (US$ million) Projections, 2024 to 2034
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
8.3. Revenue Opportunity Scenario-Conservative/Likely/Optimistic
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ million) and Volume (Units) By Product, 2019 to 2023
9.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast By Product, 2024 to 2034
9.3.1. Retractable
9.3.1.1. Manual Retractable Safety Syringes
9.3.1.2. Automatic Retractable Safety Syringes
9.3.2. Non-retractable
9.3.2.1. Sliding Needle Cover Syringes
9.3.2.2. Sheathing Tube Syringes
9.3.2.3. Hinged Needle Cover Syringes
9.4. Market Attractiveness Analysis By Product
10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ million) Analysis By Application, 2019 to 2023
10.3. Current and Future Market Size (US$ million) Analysis and Forecast By Application, 2024 to 2034
10.3.1. Subcutaneous
10.3.2. Intramuscular
10.4. Market Attractiveness Analysis By Application
11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ million) By Distribution Channel, 2019 to 2023
11.3. Current and Future Market Size (US$ million) Analysis and Forecast By Distribution Channel, 2024 to 2034
11.3.1. Direct to Customer (DTC)
11.3.2. Retail Sales
11.3.2.1. Retail Pharmacies
11.3.2.2. Drug Stores
11.3.3. Online Pharmacies
11.4. Market Attractiveness Analysis By Distribution Channel
12. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ million) By End User, 2019 to 2023
12.3. Current and Future Market Size (US$ million) Analysis and Forecast By End User, 2024 to 2034
12.3.1. Hospitals
12.3.2. Ambulatory Surgical Centers
12.3.3. Long-term Care Facilities
12.3.4. Specialty Clinics
12.3.5. Others
12.4. Market Attractiveness Analysis By End User
13. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ million) and Volume (Units) Analysis By Region, 2019 to 2023
13.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast By Region, 2024 to 2034
13.3.1. North America
13.3.2. Latin America
13.3.3. East Asia
13.3.4. South Asia and Pacific
13.3.5. Western Europe
13.3.6. Eastern Europe
13.3.7. Middle East and Africa
13.4. Market Attractiveness Analysis By Region
14. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
14.1. Introduction
14.2. Historical Market Size (US$ million) and Volume (Units) Analysis by Market Taxonomy, 2019 to 2023
14.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2024 to 2034
14.3.1. By Country
14.3.1.1. United States
14.3.1.2. Canada
14.3.1.3. Mexico
14.3.2. By Product
14.3.3. By Application
14.3.4. By Distribution Channel
14.3.5. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Application
14.4.4. By Distribution Channel
14.4.5. By End User
14.5. Market Trends
14.6. PESTEL Analysis
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
14.9. Country Level Analysis and Forecast
14.9.1. United States Market Analysis
14.9.1.1. Introduction
14.9.1.2. Market Analysis and Forecast by Market Taxonomy
14.9.1.2.1. By Product
14.9.1.2.2. By Application
14.9.1.2.3. By Distribution Channel
14.9.1.2.4. By End User
14.9.2. Canada Market Analysis
14.9.2.1. Introduction
14.9.2.2. Market Analysis and Forecast by Market Taxonomy
14.9.2.2.1. By Product
14.9.2.2.2. By Application
14.9.2.2.3. By Distribution Channel
14.9.2.2.4. By End User
14.9.3. Mexico Market Analysis
14.9.3.1. Introduction
14.9.3.2. Market Analysis and Forecast by Market Taxonomy
14.9.3.2.1. By Product
14.9.3.2.2. By Application
14.9.3.2.3. By Distribution Channel
14.9.3.2.4. By End User
15. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
15.1. Introduction
15.2. Historical Market Size (US$ million) and Volume (Units) Analysis by Market Taxonomy, 2019 to 2023
15.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2024 to 2034
15.3.1. By Country
15.3.1.1. Brazil
15.3.1.2. Chile
15.3.1.3. Rest of Latin America
15.3.2. By Product
15.3.3. By Application
15.3.4. By Distribution Channel
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Application
15.4.4. By Distribution Channel
15.4.5. By End User
15.5. Market Trends
15.6. PESTEL Analysis
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
15.9. Country Level Analysis and Forecast
15.9.1. Brazil Market Analysis
15.9.1.1. Introduction
15.9.1.2. Market Analysis and Forecast by Market Taxonomy
15.9.1.2.1. By Product
15.9.1.2.2. By Application
15.9.1.2.3. By Distribution Channel
15.9.1.2.4. By End User
15.9.2. Chile Market Analysis
15.9.2.1. Introduction
15.9.2.2. Market Analysis and Forecast by Market Taxonomy
15.9.2.2.1. By Product
15.9.2.2.2. By Application
15.9.2.2.3. By Distribution Channel
15.9.2.2.4. By End User
16. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034
16.1. Introduction
16.2. Historical Market Size (US$ million) and Volume (Units) Analysis by Market Taxonomy, 2019 to 2023
16.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2024 to 2034
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Product
16.3.3. By Application
16.3.4. By Distribution Channel
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Application
16.4.4. By Distribution Channel
16.4.5. By End User
16.5. Country Level Analysis and Forecast
16.5.1. China Market Analysis
16.5.1.1. Introduction
16.5.1.2. Market Analysis and Forecast by Market Taxonomy
16.5.1.2.1. By Product
16.5.1.2.2. By Application
16.5.1.2.3. By Distribution Channel
16.5.1.2.4. By End User
16.5.2. Japan Market Analysis
16.5.2.1. Introduction
16.5.2.2. Market Analysis and Forecast by Market Taxonomy
16.5.2.2.1. By Product
16.5.2.2.2. By Application
16.5.2.2.3. By Distribution Channel
16.5.2.2.4. By End User
16.5.3. South Korea Market Analysis
16.5.3.1. Introduction
16.5.3.2. Market Analysis and Forecast by Market Taxonomy
16.5.3.2.1. By Product
16.5.3.2.2. By Application
16.5.3.2.3. By Distribution Channel
16.5.3.2.4. By End User
17. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034
17.1. Introduction
17.2. Historical Market Size (US$ million) and Volume (Units) Analysis by Market Taxonomy, 2019 to 2023
17.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2024 to 2034
17.3.1. By Country
17.3.1.1. India
17.3.1.2. ASEAN Countries
17.3.1.3. Australia and New Zealand
17.3.1.4. Rest of South Asia and Pacific
17.3.2. By Product
17.3.3. By Application
17.3.4. By Distribution Channel
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Application
17.4.4. By Distribution Channel
17.4.5. By End User
17.5. Country Level Analysis and Forecast
17.5.1. India Market Analysis
17.5.1.1. Introduction
17.5.1.2. Market Analysis and Forecast by Market Taxonomy
17.5.1.2.1. By Product
17.5.1.2.2. By Application
17.5.1.2.3. By Distribution Channel
17.5.1.2.4. By End User
17.5.2. ASEAN Countries Market Analysis
17.5.2.1. Introduction
17.5.2.2. Market Analysis and Forecast by Market Taxonomy
17.5.2.2.1. By Product
17.5.2.2.2. By Application
17.5.2.2.3. By Distribution Channel
17.5.2.2.4. By End User
17.5.3. Australia and New Zealand Market Analysis
17.5.3.1. Introduction
17.5.3.2. Market Analysis and Forecast by Market Taxonomy
17.5.3.2.1. By Product
17.5.3.2.2. By Application
17.5.3.2.3. By Distribution Channel
17.5.3.2.4. By End User
18. Western Europe Market 2019 to 2023 and Forecast 2024 to 2034
18.1. Introduction
18.2. Historical Market Size (US$ million) and Volume (Units) Analysis by Market Taxonomy, 2019 to 2023
18.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2024 to 2034
18.3.1. By Country
18.3.1.1. Germany
18.3.1.2. Italy
18.3.1.3. France
18.3.1.4. United Kingdom
18.3.1.5. Spain
18.3.1.6. BENELUX
18.3.1.7. Rest of Western Europe
18.3.2. By Product
18.3.3. By Application
18.3.4. By Distribution Channel
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Application
18.4.4. By Distribution Channel
18.4.5. By End User
18.5. Country Level Analysis and Forecast
18.5.1. Germany Market Analysis
18.5.1.1. Introduction
18.5.1.2. Market Analysis and Forecast by Market Taxonomy
18.5.1.2.1. By Product
18.5.1.2.2. By Application
18.5.1.2.3. By Distribution Channel
18.5.1.2.4. By End User
18.5.2. France Market Analysis
18.5.2.1. Introduction
18.5.2.2. Market Analysis and Forecast by Market Taxonomy
18.5.2.2.1. By Product
18.5.2.2.2. By Application
18.5.2.2.3. By Distribution Channel
18.5.2.2.4. By End User
18.5.3. Spain Market Analysis
18.5.3.1. Introduction
18.5.3.2. Market Analysis and Forecast by Market Taxonomy
18.5.3.2.1. By Product
18.5.3.2.2. By Application
18.5.3.2.3. By Distribution Channel
18.5.3.2.4. By End User
18.5.4. Italy Market Analysis
18.5.4.1. Introduction
18.5.4.2. Market Analysis and Forecast by Market Taxonomy
18.5.4.2.1. By Product
18.5.4.2.2. By Application
18.5.4.2.3. By Distribution Channel
18.5.4.2.4. By End User
18.5.5. BENELUX Market Analysis
18.5.5.1. Introduction
18.5.5.2. Market Analysis and Forecast by Market Taxonomy
18.5.5.2.1. By Product
18.5.5.2.2. By Application
18.5.5.2.3. By Distribution Channel
18.5.5.2.4. By End User
18.5.6. United Kingdom Market Analysis
18.5.6.1. Introduction
18.5.6.2. Market Analysis and Forecast by Market Taxonomy
18.5.6.2.1. By Product
18.5.6.2.2. By Application
18.5.6.2.3. By Distribution Channel
18.5.6.2.4. By End User
19. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034
19.1. Introduction
19.2. Historical Market Size (US$ million) and Volume (Units) Analysis by Market Taxonomy, 2019 to 2023
19.3. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2024 to 2034
19.3.1. By Country
19.3.1.1. Russia
19.3.1.2. Hungary
19.3.1.3. Poland
19.3.1.4. Rest of Eastern Europe
19.3.2. By Product
19.3.3. By Application
19.3.4. By Distribution Channel
19.3.5. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Application
19.4.4. By Distribution Channel
19.4.5. By End User
19.5. Country Level Analysis and Forecast
19.5.1. Russia Market Analysis
19.5.1.1. Introduction
19.5.1.2. Market Analysis and Forecast by Market Taxonomy
19.5.1.2.1. By Product
19.5.1.2.2. By Application
19.5.1.2.3. By Distribution Channel
19.5.1.2.4. By End User
19.5.2. Hungary Market Analysis
19.5.2.1. Introduction
19.5.2.2. Market Analysis and Forecast by Market Taxonomy
19.5.2.2.1. By Product
19.5.2.2.2. By Application
19.5.2.2.3. By Distribution Channel
19.5.2.2.4. By End User
19.5.3. Poland Market Analysis
19.5.3.1. Introduction
19.5.3.2. Market Analysis and Forecast by Market Taxonomy
19.5.3.2.1. By Product
19.5.3.2.2. By Application
19.5.3.2.3. By Distribution Channel
19.5.3.2.4. By End User
20. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034
20.1. Introduction
20.2. Key Players Analyzed
20.3. Historical Market Size (US$ million) and Volume (Units) Analysis by Market Taxonomy, 2019 to 2023
20.4. Current and Future Market Size (US$ million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2024 to 2034
20.4.1. By Country
20.4.1.1. Saudi Arabia
20.4.1.2. Türkiye
20.4.1.3. South Africa
20.4.1.4. North Africa
20.4.1.5. Rest of Middle East and Africa
20.4.2. By Product
20.4.3. By Application
20.4.4. By Distribution Channel
20.4.5. By End User
20.5. Market Attractiveness Analysis
20.5.1. By Country
20.5.2. By Product
20.5.3. By Application
20.5.4. By Distribution Channel
20.5.5. By End User
20.6. Country Level Analysis and Forecast
20.6.1. Saudi Arabia Market Analysis
20.6.1.1. Introduction
20.6.1.2. Market Analysis and Forecast by Market Taxonomy
20.6.1.2.1. By Product
20.6.1.2.2. By Application
20.6.1.2.3. By Distribution Channel
20.6.1.2.4. By End User
20.6.2. Türkiye Market Analysis
20.6.2.1. Introduction
20.6.2.2. Market Analysis and Forecast by Market Taxonomy
20.6.2.2.1. By Product
20.6.2.2.2. By Application
20.6.2.2.3. By Distribution Channel
20.6.2.2.4. By End User
20.6.3. South Africa Market Analysis
20.6.3.1. Introduction
20.6.3.2. Market Analysis and Forecast by Market Taxonomy
20.6.3.2.1. By Product
20.6.3.2.2. By Application
20.6.3.2.3. By Distribution Channel
20.6.3.2.4. By End User
20.6.4. North Africa Market Analysis
20.6.4.1. Introduction
20.6.4.2. Market Analysis and Forecast by Market Taxonomy
20.6.4.2.1. By Product
20.6.4.2.2. By Application
20.6.4.2.3. By Distribution Channel
20.6.4.2.4. By End User
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Concentration
21.4. Market Presence Analysis
21.4.1. Regional Footprint Analysis
21.4.2. Product Footprint Analysis
21.4.3. Channel Footprint Analysis
22. Competition Analysis
22.1. Competition Benchmarking
22.2. Competition Dashboard
22.3. Key Development Analysis
22.4. Key Promotional Strategies
22.5. Competition Deep Dive
22.5.1. Becton, Dickinson and Company.
22.5.1.1. Overview
22.5.1.2. Product Portfolio
22.5.1.3. Sales Footprint
22.5.1.4. Key Financials
22.5.1.5. Strategy Overview
22.5.1.6. SWOT Analysis
22.5.2. AdvaCare Pharma
22.5.3. Cardinal Health Inc.
22.5.4. DMC Medical Ltd.
22.5.5. Duopross Meditech Corp.
22.5.6. Haiou Medical
22.5.7. Kendall Healthcare
22.5.8. Lifelong Meditech (Group)
22.5.9. Medicina (HMC Group)
22.5.10. Medline Industries
22.5.11. Nipro Corporation
22.5.12. Numedico
22.5.13. Nemera
22.5.14. Retractable Technologies, Inc.
22.5.15. Revolutions Medical Corporation
22.5.16. Smiths Medical, Inc. (ICU Medical, Inc.)
22.5.17. Sol-Millennium Medical Group
22.5.18. Terumo Corporation
22.5.19. UltiMed, Inc. (Ulticare)
22.5.20. Unilife Corporation
22.5.21. B. Braun Melsungen AG,
22.5.22. Fresenius Kabi AG
22.5.23. West Pharmaceutical Services, Inc.
23. Assumptions and Acronyms Used
24. Research Methodology
Explore Healthcare Insights
View Reports
Safety Syringe Market
